Las Vegas, NV -- (SBWIRE) -- 10/23/2013 -- Advaxis, Inc. (OTC:ADXS) is offering timely information to the investors and recently issued investor presentation. The company entered debt conversion agreement with the director and Ex-CEO Thomas Moore.
Advaxis will repay the loan to Mr. Moore that was offered under promissory notes. The Moore Notes, the promissory notes, are paid back $100,000 in cash and rest will be paid by converting balance into securities.
The company entered exchange agreement with Redwood Management to offer 125,000 restricted common stocks. The offering takes place in exchange with amount due.
Advaxis, Inc. operates in biotechnology industry and manufactures immunotherapies related to cancer and other diseases. Technology used by the company for treatment of HI is also under progress. Advaxis has effectively worked on immunotherapies for cancer types of prostate and HER2 expressing cancers. These HER2 expressing cancers include cancers of breast, bladder, brain, ovary and pancreas.
To find out what OTCMAGIC projects for Advaxis, Inc. for both short term and long term please click here: ADXS
OTCMAGIC Spends all day scouring the markets for the next huge Penny Stock Winner. Investors have come to trust us for our up to date commentary on all hot stocks so please visit OTCMAGIC right now and see what it’s all about for yourself! At 30,000 Visitors a Month and growing rapidly OTCMAGIC is the hottest thing in penny stocks!
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PLEASE NOTE: OTCMagic.com employees are not registered as an Investment Advisor in any jurisdiction whatsoever. Full disclaimer can be read at http://OTCMagic.com/disclaimer. Release of Liability: Through use of this website viewing or using you agree to hold OTCMagic.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss monetary or otherwise, damage monetary or otherwise, or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. OTCMagic.com affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. OTCMagic.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and OTCMagic.com. We make no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. This is not a solicitation to buy or sell any securities. Any claims or Statements should be deemed hypothetical. OTCMagic.com, nor any of its affiliates are not registered investment advisors or broker dealers.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)